In contrast to the original analyses of these data which compared MITF high proliferative melanoma cells against AXL high invasive cells, the 1252 melanoma scRNA-seq profiles from 19 patients generated by Tirosh et al. (2016) was analysed in an unsupervised manner, without prior assumption of the apparent heterogeneity. This evidence concerns the gene MITF and melanoma.